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Why cancer has renewed interest in glycolysis
Glucose is a key bioenergetic substrate for mammals, and 
the steps by which it is metabolized in cells to produce 
energy in the form of ATP were worked out long ago. As 
shown in Figure  1, these start with a series of chemical 
conversions to pyruvate (producing two ATPs) followed 
either by oxidation in the mitochondrion (producing 30 
ATPs) or the conversion of pyruvate to lactate. The steps 
from glucose to lactate constitute glycolysis, and from the 
original studies in muscle and other tissues, it was 
concluded that the main function of this pathway was to 
supply pyruvate for mitochondrial respiration to meet 
the energy demands of the cell. Conversion to lactate was 
observed only in hypoxic conditions and anaerobic 
glycolysis viewed as a temporary and much less efficient 
way to produce ATP.
This view changed when Otto Warburg noted that 
cancer cells convert glucose to lactate at a high rate in 
normoxic conditions, a phenomenon that became known 
as the Warburg effect. Having established that this 
elevated level of aerobic glycolysis was not due to 
mitochondrial defects, but an altered metabolism that 
had advantages for cancer cells, there was a renewed 
interest in studying the detailed regulation of glycolysis 
and its connected pathways. This continues today, with in 
vitro studies still adding to our understanding of the role 
of glycolysis in meeting the biosynthetic as well as 
energetic needs of cancer cells [1]. Addressing the role of 
glycolysis as tumors arise in vivo is challenging, but 
genetic engineering in mouse models can make a contri­
bution. In this regard, the work of Gershon et al. [2] on 
hexokinase­2 (HK2)­mediated aerobic glycolysis during 
cerebellar neurogenesis and the pathogenesis of medullo­
blastoma is significant, both as an in vivo confirmation of 
an important role for HK2­driven aerobic glycolysis in 
tumorigenesis, and in demonstrating a role for aerobic 
glycolysis in normal development.
Aerobic glycolysis provides anabolic carbons for 
biosynthetic pathways
Glucose uptake into normal cells is tightly regulated, but 
cancer cells are reprogrammed to fuel unrestrained 
proliferation [1] and diverse cancer types have been 
observed to take up glucose at abnormally high rates. 
Once transported across the cell membrane, glucose is 
trapped by hexokinase­mediated phosphorylation to 
form glucose­6­phosphate. In non­dividing cells this is 
mediated by HK1, but HK2 is induced in proliferating 
cells and is directly activated at the transcriptional level 
by c­Myc and hypoxia inducible factor (HIF­1) [1]. HK2 
binds to the outer mitochondrial membrane and cata­
lyzes the phosphorylation of glucose, putatively by using 
ATP generated by the mitochondrion. Unlike HK1 it is 
not inhibited by its product and can therefore drive a 
higher level of glycolysis. The phosphorylation of glucose 
is a key step that defines the uptake and retention of 
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positron emitting 19F­fluorodeoxyglucose in clinical PET 
scans of cancers. As well as being useful diagnostically, 
PET scans provide an in vivo demonstration of high 
glucose consumption by human tumors in situ.
Several glycolytic steps between HK2 and the final 
enzyme in the pathway, LDHA, are noteworthy as im­
portant regulatory points (Figure  1). Phosphofructo­
kinase (PFK) is a rate­limiting, allosterically controlled 
enzyme that catalyzes the conversion of fructose­6­
phosphate to fructose­1,6­bisphosphate (F1,6BP) before 
its conversion to 3­carbon molecules and ultimately to 
pyruvate. Regulation of PFK by the allosteric activator 
fructose­2,6­bisphosphate (F2,6BP), which is generated 
by the 6­phosphofructo­2­kinase/fructose­2,6­biphos­
phatase family, provides a means to increase glycolytic 
flux and this has been shown to be important for prostate 
cancer cell survival [3]. Alternatively, a choke point is 
created, when PFK activity diminishes, to shunt glucose 
carbons toward the pentose phosphate pathway for 
NADPH generation and redox homeostasis, which are 
critical for titrating oxygen radicals generated by mito­
chondrial respiration
Figure 1. Aerobic glycolysis, the citric acid cycle, and key glycolytic shunts. The diagram depicts glycolysis and ending with pyruvate and 
lactate. Intermediates are named and shown with space-filled models. The GLUT transporter and enzymes are shown with key rate-limiting steps 
highlighted in red. Reactions branching to the left are the pentose phosphate pathway, which produces ribose and NADPH; phosphofructokinase-
fructose bisphosphatase (PFKFB), which produces fructose-2,6-bisphosphate, an allosteric activator of phosphofructokinase (PFKM); PFKM 
production of fructose-1,6-bisphosphate; and phophoglycerate dehydrogenase (PHGDH)-mediated production of serine. The last two allosterically 
activate pyruvate kinase M2 (PKM2). Pyruvate is shown converted to acetyl-CoA for further oxidation through the citric acid cycle depicted with 
intermediates forming in the mitochondrion. HK2, hexokinase 2; GPI, glucose-6-phosphate isomerase; ALDA, aldolase A; GAPDH, glyceraldehyde-
3-phosphate dehydrogenase; PGK1, phosphoglycerate kinase 1; PGM, phosphoglycerate mutase; ENO1, enolase 1; LDHA, lactate dehydrogenase. 
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The other notable step involves pyruvate kinase M 
(PKM), which catalyzes the conversion of phospho­
enolpyruvate to pyruvate and the generation of ATP. The 
rate­limiting PKM2 isoform, resulting from a specific 
spliced mRNA form, is under allosteric control of F1,6BP 
and serine that is generated from 3PG (Figure 1) [4]. These 
mechanisms of control of PFK and PKM2 provide key 
shunts for channeling glucose carbons toward bio synthetic 
pathways or for redox homeostasis. Finally, the conversion 
of pyruvate to lactate is coupled with the recycling of 
NADH to NAD+, which is required for glyceraldehyde 
phosphate dehydrogenase (GAPDH) up stream in the 
glycolytic pathway. It appears that this recycling of NAD+ 
with the dumping of glucose carbons as lactate is essential 
for cellular redox homeostasis, because inhibition of 
LDHA results in oxidative stress­induced cell death. 
Similar to mammalian cells, proliferating yeast cells dump 
glucose as ethanol as a way to recycle NAD+.
essential role of hexokinase in tumorigenesis
Although studies have demonstrated an essential role of 
aerobic glycolysis for cultured cell proliferation and 
LDHA for tumor xenograft growth, the role of HK2 in 
mouse tumorigenesis had not been previously estab­
lished. Gershon et al. [2] document that HK2 is required 
for medulloblastoma tumorigenesis driven by a consti­
tutively active sonic hedgehog (Shh) pathway in cere­
bellar granule neuron progenitor (CGNP) cells. Stimu­
lation of isolated CGNP cells with Shh resulted in 
increased aerobic glycolysis and activation of HK2 in an 
N­Myc­Max­dependent manner, suggesting that Shh 
pathway­mediated increase in Myc activity drives HK2 
expression and glycolysis, which are both accentuated by 
HIF­1 under hypoxia. Importantly, conditional deletion 
of HK2 diminishes Shh­mediated aerobic glycolysis in 
CGNPs, indicating that normal development in this 
lineage involves glycolysis, which is commandeered for 
tumorigenesis. In this regard, Gershon et al. [2] docu­
mented that deletion of HK2 disrupted medulloblastoma 
tumorigenesis and prolonged survival.
complex role of lactate dehydrogenases in cancer
By contrast to HK2, the role of LDHs in cancer develop­
ment appears more complex. Although targeting LDHA 
with short­hairpin RNAs (shRNAs) diminishes tumor 
xenograft growth in a number of models, the reduction 
of LDHA activity in a hypomorphic mutant allele of 
LDHA did not diminish tumorigenesis in the λ­Myc 
transgenic model of murine lymphoma [5]. Although 
LDHA kinetically favors the conversion of pyruvate to 
lactate in aerobic glycolysis and is therefore important for 
tumorigenesis, LDHB could also mediate the same 
reaction, although it is more sensitive to substrate 
(pyruvate) inhibition and hence is thought to favor the 
conversion of lactate to pyruvate. Both LDHs can also 
catalyze the conversion of lactate to pyruvate, which 
could be oxidized in the mitochondrion and may be 
important for the commensal metabolic relationship 
among cancer cells in the tumor microenvironment. In 
this relationship, glycolytic hypoxic cancer cells convert 
glucose to lactate, which is taken up by cells that convert 
lactate to pyruvate for oxidation by mitochondrial 
respiration in oxygenated areas of the tumor [6]. Normal 
stromal cells in the tumor might also participate in this 
relationship. Indeed, oxidative phosphorylation appears 
to be critically important for certain cancers and in 
particular for a subset of human lymphomas [7]. LDHB 
rather than LDHA appears to be necessary for triple 
negative breast cancer cell growth [8]. Hence, the roles of 
LDHA and LDHB in aerobic glycolysis or in mito chon­
drial respiration in specific types of human cancers 
remain to be fully established.
Don’t forget about the mitochondrion and other 
nutrient sources
As already alluded to, mitochondrial respiration is essen­
tial for certain tumors to grow and progress. Further, the 
mitochondrion is a hotbed for many essential bio chem­
ical pathways used by growing cells, such as pyrimidine, 
amino acid and heme biosynthesis [9]. Thus, although 
aerobic glycolysis plays an important role in tumori­
genesis, the role of the mitochondrion should not be 
forgotten. For example, the commensal roles of hypoxic 
and aerobic cancer cells require functional mitochondria 
to use lactate as a respiratory substrate [6]. In addition, 
fatty acids, rather than glucose, could be oxidized as a 
primary bioenergetics source for lymphoma and leu­
kemia cells [7]. Aerobic glycolysis and mitochondria 
provide ATP and building blocks for cancer cells, when 
nutrients are available. Cancer cells starved of nutrients 
could survive and proliferate by eating cellular compo­
nents via autophagy or adapt by eating macromolecules 
from their environment by macropinocytosis [10].
In summary, the work of Gershon et al. [2] definitively 
documents a role for HK2 and aerobic glycolysis for the 
generation of medulloblastoma in mice and underscores 
the importance of the Warburg effect in tumorigenesis . 
However, the loss of HK2 prolonged survival but did not 
fully block tumorigenesis, suggesting that tumorigenesis 
could rely on alternative metabolic pathways. Studies of 
tumors arising from targeted deletion of HK2 could lead 
to additional insights into metabolic reprogramming in 
tumorigenesis and the role of the tumor microenvironment.
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